Antiplatelet effects of prostacyclin and nitric oxide in patients with type I diabetes and ischemic or edematous retinopathy

Platelets

Volumn 12, Issue 4, 2001, Pages 210-217

  De La Cruz, J P ^a   Moreno, A ^a   Guerrero, A ^a   Sanchez de la Cuesta F ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARGININE; CYCLIC AMP; CYCLIC GMP; NITRATE; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROSTAGLANDIN E;

ADULT; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; SECOND MESSENGER; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; EPOPROSTENOL; FEMALE; HUMANS; MALE; NITRIC OXIDE; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS;

EID: 0034949167     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537100120058748     Document Type: Article

References (31)

1. Evaluating policies for the early detection of retinopathy in patients with non-insulin dependent diabetes
2. Incidence of retinopatliy and associated risk factors from time of diagnosis of insulin-dependent diabetes
3. Ophthalmic health care in diabetes mellitus: A cross-sectional study in northern Sweden
4. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
5. Endothelial disfunction in diabetes
6. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis
7. The biological and pharmacological role of nitric oxide in platelet function
8. Laboratory markers of platelet activation and their clinical significance
9. Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients
10. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus
11. Improved glycemic control and platelet function abnormalities in diabetic patients with microvascular disease
12. Diabetes-induced alterations in platelet metabolism
13. Platelet hyperaggregation in diabetic patients with different types of retinopathy is partially influenced by erythrocytes in whole blood
14. The electronic aggregometer: A novel device for assessing platelet behaviour in blood
15. Altered cellular signalling and decreased platelet sensitivity to adenosine in insulin-dependent diabetic patients with proliferative retinopathy
16. Inhibition of platelet aggregation by L-arginine and polyamines in alloxan treated rats
17. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus
18. Nitrite plasma levels in type 1 and 2 diabetics with and without complications
19. Platelet cNOS activity is reduced in patients with IDDM and NIDDM
20. Decreased nitric oxide synthase activity in patients with IDDM and NIDDM patients
21. NO-dependent smooth muscle vasodilation is reduced in NIDDM patients with peripheral sensory neuropathy
22. Nitric oxide-dependent soluble guanylate cyclase activity is decreased in platelets from male NIDDM patients
23. Radicals and oxidative stress in diabetes
24. Consequences of the diabetic status on the oxidant/antioxidant balance
25. Nitric oxide: Physiology, pathophysiology, and pharmacology
26. Paradoxical fate and biological action of peroxynitrite on human platelets
27. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite
28. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets
29. Prostacyclin/thromboxane balance and retinal vascular pattern in diabetic rats
30. Effect of antiplatelet drug therapy on the retinal vascular pattern in experimental diabetes
31. Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus